Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,519,204
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001804350-21-000001
Form type
SC 13G/A
Filer
Hardie Robert D.
CIK
CIK 1804350
Filed
Feb 16, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub